Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1996-9-12
pubmed:abstractText
1. The effects of a single oral dose (50 mg) of the angiotensin II AT1-receptor antagonist, losartan, on the systemic and regional vascular responses to simulated orthostatic stress by the lower body negative pressure (LBNP) technique were investigated in nine healthy volunteers, in a double-blind, placebo-controlled crossover study. 2. Arterial blood pressure remained unchanged throughout the study. Three hours after its administration and before LBNP, losartan selectively increased renal blood flow (PAH clearance) by 8.3% (3.5 to 13.1%, 95% CI) from 1.25 +/- 0.08 l min-1 (P < 0.05) and decreased plasma aldosterone levels by 58% (29 to 87%, 95% CI) from 22 +/- 3 ng 100 ml-1 (P < 0.05). 3. LBNP at -10 and -20 mm Hg induced a progressive and significant decrease in central venous pressure and increases in forearm (plethysmography) and splanchnic (indocyanine green clearance) vascular resistances which were similar after losartan and placebo administrations. Losartan blunted the LBNP-induced increase in renal vascular resistance observed at -20 mm Hg after placebo but a similar increase in glomerular filtration rate (inulin clearance) was observed at LBNP -10 and -20 mm Hg after losartan and placebo. Calculated filtration fraction increased after placebo (LBNP -10 mm Hg) and losartan (LBNP -20 mm Hg). Finally, LBNP-induced changes in biological parameters were similar after losartan and placebo at all levels of LBNP. 4. Thus, losartan does not interfere with the adaptive forearm and splanchnic vascular responses and preserves renal haemodynamics during orthostatic stress simulated by LBNP in healthy volunteers.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-1389945, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-13950177, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-1464825, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-1524759, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-1587065, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-1630072, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-1719293, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-1854460, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-1854464, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-2013151, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-2045159, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-2179532, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-2185150, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-2313596, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-2318763, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-234806, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-2551874, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-3006218, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-3066877, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-4826928, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-5082190, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-5746, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-6094343, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-6298103, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-6364845, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-7026873, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-7304981, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-7505360, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-7685442, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-7690084, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-8349327, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-8403307, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-8456981, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-8491505, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-87679, http://linkedlifedata.com/resource/pubmed/commentcorrection/8703646-998804
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0306-5251
pubmed:author
pubmed:issnType
Print
pubmed:volume
40
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
431-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
1995
pubmed:articleTitle
Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers.
pubmed:affiliation
Services d'Anesthésiologie, Hôpital de Bicêtre, Le Kremlin Bicêtre, France.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Controlled Clinical Trial, Research Support, Non-U.S. Gov't